Does allergy immunotherapy (subcutaneous or sublingual) affect blood pressure?

Does Allergy Immunotherapy Affect Blood Pressure?

Allergy immunotherapy itself does not directly affect blood pressure in a clinically meaningful way, though patients on certain cardiovascular medications (ACE inhibitors and beta-blockers) require special consideration due to potential complications from systemic reactions, not from blood pressure effects of the immunotherapy itself.

Key Clinical Considerations

The 2011 practice parameter guidelines 1 specifically address cardiovascular medications in the context of immunotherapy safety, but focus on their impact on managing potential systemic reactions (including anaphylaxis), not on blood pressure changes from the immunotherapy:

Beta-Blockers

• Cardioselective beta-blockers carry unknown risk during immunotherapy, though severe anaphylaxis cases from other causes have been reported in patients on these medications 1
• The concern is that beta-blockers may complicate treatment of anaphylactic reactions, not that immunotherapy changes blood pressure

ACE Inhibitors

• Conflicting evidence exists regarding ACE inhibitors and immunotherapy risk 1
• Two retrospective studies found no increased systemic reaction frequency in patients on ACE inhibitors receiving venom or inhalant immunotherapy
• However, case reports and one prospective study (962 patients) found ACE inhibitors associated with more severe reactions from venom immunotherapy
• The guideline recommends considering ACE inhibitor discontinuation for patients receiving venom immunotherapy, though concurrent use may be warranted when no equally effective alternative exists and risk/benefit is favorable 1

Evidence on Blood Pressure and Allergic Disease

The relationship between allergies and blood pressure is complex but relates to the underlying allergic disease, not the immunotherapy treatment:

• One study found that treating allergic rhinitis with conventional medications (fluticasone nasal spray and fexofenadine) reduced systolic blood pressure by 7.4 mm Hg in hypertensive patients with allergic rhinitis, suggesting allergic inflammation itself may elevate blood pressure 2

• A 2018 population-based study found no significant blood pressure differences between allergic rhinitis patients and controls, concluding that rhinitis was not associated with increased blood pressure and does not require blood pressure follow-up 3

Clinical Algorithm

For patients considering immunotherapy:

1. Review current medications - identify beta-blockers or ACE inhibitors
2. If on ACE inhibitors and receiving venom immunotherapy - strongly consider discontinuation or switching to alternative antihypertensive
3. If on beta-blockers - discuss unknown risks; cardioselective agents may be preferable but risk remains unclear
4. Monitor for systemic reactions (the actual concern) - patients must remain in office 30 minutes post-injection 1
5. Blood pressure monitoring is not specifically required due to immunotherapy itself

Important Caveats

• The medication concerns relate to managing potential anaphylaxis, not direct blood pressure effects of immunotherapy
• Immunotherapy safety data consistently show it is well-tolerated with rare systemic reactions 4
• Any blood pressure relationship is more likely related to the underlying allergic inflammation rather than the immunotherapy treatment itself